Pink Sheet is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

First FDA Center Of Excellence For Regulatory Science Looks At Nanotechnology

This article was originally published in The Pink Sheet Daily

Executive Summary

National Center for Toxicological Research signs agreement setting up CERS in Arkansas.
Advertisement

Related Content

FDA Advisors Want More Data On Nanotech Sunscreens
FDA Advisors Want More Data On Nanotech Sunscreens
Foreign Regulator Exchange Program Contemplated By U.S. State Department
Foreign Regulator Exchange Program Contemplated By U.S. State Department
Good Neighbors Make Good Regulatory Science Centers, FDA Decides
FDA's Medical Countermeasure Program Among Senate Funding Priorities
FDA's Medical Countermeasure Program Among Senate Funding Priorities
Regulatory Science Next To Be Outsourced?
FDA Has Regulatory Science Plan; Now It Needs Funding
FDA Has Regulatory Science Plan; Now It Needs Funding

Topics

Advertisement
UsernamePublicRestriction

Register

PS072637

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel